Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

• Arsenic Trioxide Combined With Chemotherapy for Relapsed SHH-Activated and/or TP53-Mutant Medulloblastoma

  Phase 2, Not yet recruiting, 78 people, 2 Oct 2026

• NCT07728955

  Phase 3, Not yet recruiting, 64 people, 27 Jul 2026

• NCT07717242

  Phase 2, Recruiting, 80 people, 21 Jul 2026

• NCT07595900

  Phase 1/2, Not yet recruiting, 31 people, 19 May 2026

• NCT07544056

  Collaborator, Phase 2/3, Recruiting, 446 people, 22 Apr 2026

• NCT07401654

  Phase 2, Not yet recruiting, 60 people, 10 Feb 2026

• NCT07371910

  Phase 3, Active, not recruiting, 200 people, 28 Jan 2026

• NCT07119996

  Phase 1, Recruiting, 12 people, 13 Aug 2025

• NCT06810791

  Collaborator, Phase 3, Recruiting, 876 people, 6 Feb 2025

• NCT06763666

  Collaborator, Phase 4, Not yet recruiting, 172 people, 8 Jan 2025

• NCT06511726

  Phase 2, Active, not recruiting, 29 people, 22 Jul 2024

• NCT06409637

  Phase 1/2, Not yet recruiting, 62 people, 10 May 2024

• NCT06404775

  Phase 3, Not yet recruiting, 456 people, 8 May 2024

• NCT06366945

  Phase 2, Not yet recruiting, 85 people, 16 Apr 2024

• NCT06364904

  Phase 3, Not yet recruiting, 210 people, 15 Apr 2024

• NCT06289751

  Collaborator, Phase 2, Recruiting, 50 people, 4 Mar 2024

• NCT06144944

  Phase 3, Active, not recruiting, 160 people, 22 Nov 2023

• NCT06121557

  Phase 1, Recruiting, 24 people, 8 Nov 2023

• NCT06121570

  Phase 1, Recruiting, 24 people, 8 Nov 2023

• NCT06016413

  Phase 2, Not yet recruiting, 30 people, 29 Aug 2023

Sources: clinicaltrials.gov